Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.04. | Piper Sandler sets RxSight stock target at $18, stays neutral | 1 | Investing.com | ||
09.04. | RxSight downgraded at UBS after Q1 miss and guidance cut | 4 | Seeking Alpha | ||
09.04. | UBS cuts RxSight stock rating to neutral, slashes price target to $16 | 2 | Investing.com | ||
04.04. | SA Rating Changes: CHTR, RIVN, EE, WASH, DV, LZ, RXST | 7 | Seeking Alpha | ||
04.04. | JP Morgan downgrades RxSight on market, competitive pressures | 4 | Investing.com | ||
04.04. | Deep Dive Into RxSight Stock: Analyst Perspectives (12 Ratings) | 3 | Benzinga.com | ||
RXSIGHT Aktie jetzt für 0€ handeln | |||||
03.04. | JPMorgan cuts RxSight stock rating, slashes price target to $17 | 3 | Investing.com | ||
03.04. | Rxsight adjusts 2025 revenue guidance to $160M-$175M amid premium IOL market challenges | 1 | Seeking Alpha | ||
03.04. | RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations | 1 | Benzinga.com | ||
03.04. | RxSight-Aktie stürzt nach gesenkter Prognose für 2025 ab | 3 | Investing.com Deutsch | ||
03.04. | RxSight stock tumbles on lowered 2025 guidance | 1 | Investing.com | ||
03.04. | BTIG cuts RxSight stock price target to $28 from $44 | 1 | Investing.com | ||
03.04. | Stifel maintains RxSight stock hold, price target at $28 | 1 | Investing.com | ||
03.04. | RxSight plunges after guidance cut | 2 | Seeking Alpha | ||
03.04. | RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges | 1 | Benzinga.com | ||
03.04. | Needham maintains Buy on RxSight stock, price target at $43 | 1 | Investing.com | ||
03.04. | RxSight Expects 28% Growth In Q1 Revenue; Cuts FY25 Revenue Outlook | 1 | RTTNews | ||
03.04. | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | 147 | GlobeNewswire (Europe) | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
21.03. | BofA cuts RxSight stock price target to $36, maintains Buy rating | 2 | Investing.com | ||
19.03. | The Analyst Verdict: RxSight In The Eyes Of 9 Experts | 2 | Benzinga.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 53,00 | 0,00 % | Eckert & Ziegler Aktie: Fortschritte in Serie! | Die Aktie des Medizintechnik-Spezialisten legt kräftig zu - Analysten prognostizieren weiteres Wachstumspotenzial. Die Eckert & Ziegler Aktie legte am Montag kräftig zu und notierte mit einem Plus von... ► Artikel lesen | |
UNITEDHEALTH | 401,35 | +0,50 % | Dow Jones: UnitedHealth-Schock! | News von Trading-Treff.de Schwere Zeiten für den Dow Jones. Die Aktie der UnitedHealth Group (UNH) stürzt ab und zieht den gesamten Index mit nach unten. Am heutigen Donnerstag fiel der Index um 1,01... ► Artikel lesen | |
HIMS & HERS HEALTH | 23,800 | -0,58 % | Hims & Hers ist kollabiert. Jetzt die Gelegenheit nutzen? | Hims & Hers revolutioniert den Gesundheitsmarkt - und das mit einer Strategie, die mehr an Netflix als an eine Arztpraxis erinnert Den vollständigen Artikel lesen ... ► Artikel lesen | |
RESMED | 187,90 | +0,35 % | Resmed, Inc.: Resmed Names Salli Schwartz as Chief Investor Relations Officer | ||
SENSEONICS | 0,530 | -1,12 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results | Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately... ► Artikel lesen | |
BONESUPPORT | 28,220 | +0,57 % | Bonesupport Holding Aktie: Leichter Aufwärtstrend | Die Aktie des Medizintechnik-Spezialisten legt weiter zu, während Analysten trotz hoher Bewertung optimistisch bleiben. Steht das bevorstehende Quartalsergebnis im Fokus? Die Aktie des schwedischen... ► Artikel lesen | |
LANTHEUS | 87,02 | -2,36 % | Lantheus Holdings, Inc.: Lantheus Completes Acquisition of Evergreen Theragnostics | BEDFORD, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians... ► Artikel lesen | |
TRANSMEDICS GROUP | 76,66 | -1,21 % | P/E Ratio Insights for TransMedics Group | ||
INSPIRE MEDICAL SYSTEMS | 128,30 | -2,91 % | Stifel cuts Inspire Medical target to $175, maintains Hold | ||
ALPHATEC | 9,018 | 0,00 % | Alphatec stock holds Buy rating and $20 target at H.C. Wainwright | ||
JOINT CORP | 9,670 | -3,40 % | The Joint Corp. Reports Fourth Quarter and Year-end 2024 Financial Results | - Grew revenue from continuing operations 10% annually and 14% quarterly compared to the same period in 2023 - - Increased system-wide sales 9% for both the year and Q4 2024 - SCOTTSDALE, Ariz.,... ► Artikel lesen | |
CHEMOMETEC | 64,25 | +0,08 % | Chemometec A/S: Interim report 2024/25 - Solid H1 performance driven by growth in both revenue and earnings | ANNOUNCEMENT NO. 2875 February 2025 Solid H1 performance driven by growth in both revenue and earnings Martin Helbo Behrens, CEO: The growth continued in the second quarter of 2024/25, and revenue... ► Artikel lesen | |
OPTIMIZERX | 8,350 | -1,18 % | OptimizeRx Corp - 8-K, Current Report | ||
PROCEPT BIOROBOTICS | 53,43 | +0,75 % | Piper Sandler maintains $100 target on Procept BioRobotics stock | ||
GENEDX | 91,05 | -4,63 % | GeneDx To Buy Fabric Genomics |